• 
• http://www.nature.com/pcan
• Editor: Professor Roger S. Kirby; Judd W. Moul, MD
• Volume 11: 4 issues per year
• ISSN: 1366-7842
• EISSN: 1476-5608
• Impact factor : 2.024*
• Impact ranking: 25/55 in Urology and Nephrology, 88/132 in Oncology*
• Date Established: 1997
• Published on behalf of:

Aims and Scope:

Prostate Cancer and Prostatic Diseases publishes papers on all aspects of prostatic diseases. The journal reports on exciting developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Topics include screening, diagnosis, surgery, radiotherapy, epidemiology, hormone therapy, molecular biology and genetics, gene therapy, biochemical markers, new technologies, prognostic indicators, chemotherapeutics, treatment options and immunological approaches.

Readership:

Clinicians and researchers treating all aspects of prostate cancer and prostatic diseases, including urologists and oncologists.

Prostate Cancer and Prostatic Diseases provides:

• Research Highlights and Original Articles - high quality, original research communicating significant findings in the field of prostate cancer and prostatic diseases.
• Review Articles - top researchers reveal cutting-edge advances in their respective areas of expertise providing readers with an authoritative overview of new developments in their fields.
• The journal also publishes topical comment, critical appraisals of scientific meetings and the latest books, and a calendar of forthcoming scientific events.

What makes Prostate Cancer and Prostatic Diseases stand apart from other resources?

• Accessibility to a broad readership - articles published in Prostate Cancer and Prostatic Diseases are accompanied by supplementary information in the form of text, figures, tables, or images, giving greater insight into primary research.
• Advanced User Functionality - the clean design of Prostate Cancer and Prostatic Diseases facilitates easy navigation and retrieval of information for users, including those using assistive technology.
• Unique Online Features - selected articles are published online in advance of appearing in the print version, providing immediate access to the latest research.

Online features and site license access:

• Online archive available back to September 1997.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period. Archive content is freely available after five years.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in Medline (PubMed), EMBASE, Current Contents Clinical Medicine, Research Alert, SciSearch, SciExpanded, Science Citation Index and UK Health Centre Index.

*2007 Journal Citation Report (Thomson Reuters, 2008)